CRESCENT BIOPHARMA, INC. (CBIO) › Shareholders' EquityCRESCENT BIOPHARMA, INC. (CBIO) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2011: $8.46M2012: $12.53M2013: $2.91M2014: $50.80M2015: $40.47M2016: $35.30M2017: $119.70M2018: $205.46M2019: $154.20M2020: $128.22M2021: $81.60M2022: $42.93M2023: $38.41M2024: -$15.48M2025: $203.01M$203.01M2011Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$203.01M+1411.5%2024-$15.48M-140.3%2023$38.41M-10.5%2022$42.93M-47.4%2021$81.60M-36.4%2020$128.22M-16.8%2019$154.20M-25.0%2018$205.46M+71.6%2017$119.70M+239.1%2016$35.30M-12.8%2015$40.47M-20.3%2014$50.80M+1647.4%2013$2.91M-76.8%2012$12.53M+48.1%2011$8.46M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share